Vanzacaftor-Tezacaftor as an alternative therapeutic resource for the ETI-Resistant L467F-F508del Allele: Ex vivo prediction and exploratory clinical assessment

Journal of Cystic Fibrosis · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles